GLP-1 weight-loss effects may endure after stopping therapy, real-world data suggests
TL;DR
Real-world data cited by Reuters via Fresh Stock Ideas suggests a sizable share of patients using Novo Nordisk and Eli Lilly GLP-1 obesity drugs may maintain weight loss for months after discontinuing the treatment.
- Study sheds light on weight regain after GLP-1 discontinuation Seeking Alpha
- It’s 2026, and We Still Don’t Know Much About Long-Term GLP Use Medscape
- Many patients may keep off lost pounds after stopping a GLP-1, US data suggests Reuters
- Many patients may keep off lost pounds after stopping a GLP-1, U.S. data suggests CTV News
- Study reveals how rapidly weight comes back after quitting obesity medications Fox News
Want the full story? Read the original reporting
Read on Seeking Alpha